Cholestatic jaundice as the predominant presentation in a patient with autoimmune hepatitis

Journal of the Chinese Medical Association

Volumn 71, Issue 1, 2008, Pages 45-48

  Tang, Chia Pei ^a   Shiau, Yih Tsong ^b   Huang, Yi Hsiang ^b,c   Tsay, Shih Haw ^b   Huo, Teh Ia ^b,c   Wu, Jaw Ching ^b,c   Lin, Han Chieh ^b,c   Lee, Shou Dong ^b,c  

^a BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Autoantibody; Autoimmune hepatitis; Jaundice

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; HLA ANTIGEN; PREDNISOLONE;

ADULT; ANTIGEN DETECTION; ARTICLE; AUTOIMMUNE HEPATITIS; CASE REPORT; CELL INFILTRATION; CHOLANGITIS; DRUG RESPONSE; FEMALE; HISTOPATHOLOGY; HUMAN; HYPERBILIRUBINEMIA; LIVER BIOPSY; LOW DRUG DOSE; OBSTRUCTIVE JAUNDICE; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; MIDDLE AGED;

FEMALE; HEPATITIS, AUTOIMMUNE; HUMANS; HYPERBILIRUBINEMIA; JAUNDICE, OBSTRUCTIVE; MIDDLE AGED;

EID: 41649117770     PISSN: 17264901     EISSN: 17287731     Source Type: Journal    
DOI: 10.1016/S1726-4901(08)70072-8     Document Type: Article

References (13)

1. Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, Champman RW, et al. International Autoimmune Hepatitis Group report: review of criteria for diagnosis of autoimmune hepatitis. J Heparol 1999;31:929-38.
2. Johnson PJ, McFarlane IG. Meeting report: International Autoimmune Hepatitis Group. Heparology 1993;18:998-1005.
3. Czaja AJ, Freese DK. Diagnosis and treatment of autoimmune hepatitis. Hepatology 2002;36:479-97.
4. Czaja A. Natural history, clinical features, and treatment of autoimmune hepatitis. Semin Liver Dis 1984;4:1-12.
5. Huang FIC, Huang YS, Wu JC, Tsay SH, Huo TI, Wang YJ, Lo JC, et al. Characteristics of autoimmune hepatitis in Taiwan: 11 years' experiences of a medical center. J Chin Med Assoc 2002;65:563-9.
6. Huo TL, Wu JC, Huang YS, Lai CR, Tsay SH, Lee SD. Autoimmune hepatitis in an area endemic for hepatitis B virus infection: a report of three cases. J Chin Med Assoc 1996; 57:360-4.
7. Czaja AJ. Autoimmune liver disease. Curr Opin Gastroenterol 2004;20:231-40.
8. McFarlane IG. Autoimmune liver diseases. Scand J Clin Lab Invest 2001;235(Suppl):53-60.
9. Czaja AJ, Donaldson PT. Gender effects and synergisms with histocompatibility leukocyte antigens in type I autoimmune hepatitis. Am J Gastroenterol 2002;97:2051-7.
10. Lo GH. Autoimmune hepatitis: truly a rare disorder in Taiwan. J Chin Med Assoc 2002;65:561-2.
11. Czaja AJ, Carpenter HA. Progressive fibrosis during corticosteroid therapy of autoimmune hepatitis. Hepatology 2004;39: 1631-8.
12. Sanchez-Urdazpal LS, Czaja AJ, van Hoek B, Krom RA, Wiesner RH. Prognostic features and role of liver transplantation in severe corticosteroid-treated autoimmune chronic active hepatitis. Hepatology 1992;15:215-21.
13. Lee YM, Teo EK, NG TM, Khor C, Fock KM. Autoimmune hepatitis in Singapore: a rare syndrome affecting middle-aged woman. J Gastroenterol Hepatol 2001;16:1384-9.